EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access

Facial Nerve Schwannoma Treatment with Stereotactic Radiosurgery (SRS) versus Resection followed by SRS: Outcomes and a Management Protocol

Sam Dayawansa iD, Chloe Dumot, Georgios Mantziaris, Gautam U Mehta iD, Gregory P Lekovic, Douglas Kondziolka, David Mathieu iD, Wael A Reda, Roman Liscak, Lee Cheng-Chia, Anthony M Kaufmann, Gene Barnet und 3 weitere

Journal of Neurological Surgery Part B: Skull Base · 01.02.2024 · 85 (01) · 075-080

DOI: 10.1055/a-1990-2861 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.02.2024. Verfasst von Sam Dayawansa und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University of Virginia Gamma Knife Surgery Center, Charlottesville, Virginia, United States. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Stereotactic radiosurgery (SRS) and resection are treatment options for patients with facial nerve schwannomas without mass effect.

Objective

This article evaluates outcomes of patients treated with SRS versus resection + SRS.

Method

We retrospectively compared 43 patients treated with SRS to 12 patients treated with resection + SRS. The primary study outcome was unfavorable combined endpoint, defined as worsening or new clinical symptoms, and/or tumor radiological progression. SRS (38.81 ± 5.3) and resection + SRS (67.14 ± 11.8) groups had similar clinical follow-ups.

Results

At the time of SRS, the tumor volumes of SRS (mean ± standard error; 1.83 ± 0.35 mL) and resection + SRS (2.51 ± 0.75 mL) groups were similar. SRS (12.15 ± 0.08 Gy) and resection + SRS (12.16 ± 0.14 Gy) groups received similar radiation doses. SRS group (42/43, 98%) had better local tumor control than the resection + SRS group (10/12, 83%, p = 0.04). Most of SRS (32/43, 74%) and resection + SRS (10/12, 83%) group patients reached a favorable combined endpoint following SRS (p = 0.52). Considering surgical associated side effects, only 2/10 patients of the resection + SRS group reached a favorable endpoint (p < 0.001). Patients of SRS group, who are > 34 years old (p = 0.02), have larger tumors (> 4 mL, 0.04), internal auditory canal (IAC) segment tumor involvement (p = 0.01) were more likely to reach an unfavorable endpoint. Resection + SRS group patients did not show such a difference.

Conclusion

While resection is still needed for larger tumors, SRS offers better clinical and radiological outcomes compared to resection followed by SRS for facial schwannomas. Younger age, smaller tumors, and non-IAC situated tumors are factors that portend a favorable outcome.

Schlagwörter

Stichwörter der Autor:innen

facial nerveinternal auditory canalschwannomastereotactic radiosurgery

Autor:innen und Institutionen

  • Department of Neurosurgery, University of Virginia Gamma Knife Surgery Center, Charlottesville, Virginia, United States.
  • Department of Neurosurgery, University of Virginia, Charlottesville, Virginia, United States.
  • Department of Neurological Surgery, House Ear Institute, Los Angeles, California, United States.
  • Department of Neurological Surgery, Charlottesville, Virginia, United States.
  • Department of Neurosurgery, House Clinic, Los Angeles, California, United States.
  • Department of Neurosurgery, New York University Medical Center, New York, New York, United States.

ORCID-Profile: Sam Dayawansa, Gautam U Mehta, David Mathieu, Daniel M Trifiletti

Zitieren

APA

Dayawansa, S., Dumot, C., Mantziaris, G., Mehta, G. U., Lekovic, G. P., Kondziolka, D., Mathieu, D., Reda, W. A., Liscak, R., Cheng-Chia, L., Kaufmann, A. M., Barnet, G., Trifiletti, D. M., Lunsford, L. D., & Sheehan, J. (2024). Facial Nerve Schwannoma Treatment with Stereotactic Radiosurgery (SRS) versus Resection followed by SRS: Outcomes and a Management Protocol. Journal of Neurological Surgery Part B: Skull Base, 85(01), 075-080. https://doi.org/10.1055/a-1990-2861

Vancouver

Dayawansa S, Dumot C, Mantziaris G, Mehta GU, Lekovic GP, Kondziolka D, et al. Facial Nerve Schwannoma Treatment with Stereotactic Radiosurgery (SRS) versus Resection followed by SRS: Outcomes and a Management Protocol. Journal of Neurological Surgery Part B: Skull Base. 2024;85(01):075-080. doi:10.1055/a-1990-2861

BibTeX
@article{Dayawansa2024,
  author = {Dayawansa, Sam and Dumot, Chloe and Mantziaris, Georgios and Mehta, Gautam U and Lekovic, Gregory P and Kondziolka, Douglas and Mathieu, David and Reda, Wael A and Liscak, Roman and Cheng-Chia, Lee and Kaufmann, Anthony M and Barnet, Gene and Trifiletti, Daniel M and Lunsford, L Dade and Sheehan, Jason},
  title = {Facial Nerve Schwannoma Treatment with Stereotactic Radiosurgery (SRS) versus Resection followed by SRS: Outcomes and a Management Protocol},
  journal = {Journal of Neurological Surgery Part B: Skull Base},
  year = {2024},
  volume = {85},
  number = {01},
  pages = {075--080},
  doi = {10.1055/a-1990-2861}
}
Kostenlos starten →